Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2000

View Archived Issues

Abbott's novel antifungal lipopeptide characterized in vitro

Ribavirin analogue ICN-17261 may have therapeutic advantages over ribavirin in HCV

Brain-selective nicotinic agonist RJR-1734 enhances ACh release

Increasing KYNA blocks nicotine-induced excitation of dopamine neurons

Tularik initiates phase II studies of T-64 for treatment of solid tumors

AdProTech signs research agreement with Chiron

New label change granted for Wyeth-Ayerst's Effexor XR

NewBiotics' NB-2001 may eliminate resistant bacteria

Long-acting human insulin analogue now available to patients in Germany

Purines 2000: a potent and selective A2B antagonist effective in asthma, retinopathy

Discovery and properties of new apoptosis inhibitor produced by Streptomyces

HIV-targeted repressor protein designed for intracellular immunization

Intranasal IM-862 effective and safe in patients with AIDS-related Kaposi's sarcoma

Improved resistance and crossresistance profiles for second-generation NNRTIs

CPT 2000 highlights: greater AUC results in greater acid inhibition with esomeprazole

Cephalon to acquire Anesta; combined company will have stronger pipeline

Pharmacopeia identifies active compounds in lead discovery program with Roche Bioscience

Peptide analogues of GLP-1 particularly useful for diabetes

Algos shareholders approve merger with Endo

G-protein-targeted antisense oligonucleotides patented by Isis

Wyeth-Ayerst accepts four novel CNS gene candidates from Millennium

Takeda patents thiazolidine MMP inhibitors

Trizivir receives positive opinion from European CPMP

Synthesis, activity and use of new neovascularization inhibitors disclosed by Takeda

Novel antidepressants with serotonergic mechanisms in the Lundbeck pipeline

Yamanouchi presents new quinolones with useful activity against H. pylori

Dual ETA/ETB receptor antagonists claimed by Kowa as cardiovascular therapeutics

Onyx and Bayer begin clinical testing of Ras inhibitor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...